76 results
424B4
LGVN
Longeveron Inc - Ordinary Shares
17 Apr 24
Prospectus supplement with pricing info
5:07pm
commercialization, and broad use by the healthcare community.
In November of 2023, Longeveron received notice from the World Health Organization (“WHO … in the investment community that generate or influence sales volume, and even if we came to the attention of such persons, they tend to be risk-averse and may
424B4
LGVN
Longeveron Inc - Ordinary Shares
10 Apr 24
Prospectus supplement with pricing info
7:48am
community.
In November of 2023, Longeveron received notice from the World Health Organization (“WHO”) that “Laromestrocel” has been selected … in the investment community that generate or influence sales volume, and even if we came to the attention of such persons, they tend to be risk-averse
FWP
LGVN
Longeveron Inc - Ordinary Shares
8 Apr 24
Free writing prospectus
8:45am
program among families of prospective patients, fostering community engagement and support.
Additionally, we plan to meet with the FDA to ensure
424B5
65q2erd
22 Dec 23
Prospectus supplement for primary offering
8:36am
424B3
dclui636
6 Dec 23
Prospectus supplement
4:05pm
424B5
tlwhswwx6i s0c
13 Oct 23
Prospectus supplement for primary offering
6:07am
8-K
EX-99.1
ooqrecewgz9hk oat7i
5 Oct 23
Longeveron Announces Positive Top-Line Results for Lomecel-BTM in its CLEAR MIND Phase 2a Clinical Trial in the Treatment of Mild Alzheimer’s Disease
7:36am
424B3
yyqoo m29vk0sekkjp3s
14 Aug 23
Prospectus supplement
4:45pm